Á lódáil...
Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination
Canagliflozin–metformin is one of the newest combination therapies available for the treatment of type 2 diabetes mellitus (T2DM). Canagliflozin is an inhibitor of the sodium–glucose co-transporter 2 which causes an increase in the urinary excretion of glucose. In the present article, we review the...
Na minha lista:
| Foilsithe in: | Diabetes Metab Syndr Obes |
|---|---|
| Main Authors: | , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Dove Medical Press
2015
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485795/ https://ncbi.nlm.nih.gov/pubmed/26150733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S69282 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|